Peptide-based tachykinin NK2 receptor antagonists.
Quartara
L
L
Chemistry Department, A. Menarini Industrie Farmaceutiche Riunite, Firenze, Italy.
Rovero
P
P
Maggi
C A
CA
D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D006801:Humans; D015288:Neurokinin A / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology; D015287:Neurokinin B / Q000037:antagonists & inhibitors / Q000502:physiology; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000494:pharmacology; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors; D018039:Receptors, Tachykinin / Q000037:antagonists & inhibitors* / Q000502:physiology; D013373:Substance P / Q000037:antagonists & inhibitors / Q000502:physiology
D004151:Dipeptides; D009842:Oligopeptides; C093467:PD 147714; D010446:Peptide Fragments; D010455:Peptides; D010456:Peptides, Cyclic; D018041:Receptors, Neurokinin-2; D018039:Receptors, Tachykinin; C073361:cyclo(Gln-Trp-Phe-Gly-Leu-Met); C076938:R 396; C069192:neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-; C093465:GR 112000; C090951:MEN 10627; D013373:Substance P; D015288:Neurokinin A; D015287:Neurokinin B